Leslie E Cofie1, Jacqueline M Hirth2, Fangjian Guo2, Abbey B Berenson2, Kyriakos Markides3, Rebeca Wong3. 1. Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas; Center for Interdisciplinary Research in Women's Health, University of Texas Medical Branch, Galveston, Texas. Electronic address: lecofie@utmb.edu. 2. Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas; Center for Interdisciplinary Research in Women's Health, University of Texas Medical Branch, Galveston, Texas. 3. Center for Interdisciplinary Research in Women's Health, University of Texas Medical Branch, Galveston, Texas; Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, Texas.
Abstract
INTRODUCTION: Human papillomavirus vaccination is less prevalent among foreign-born than U.S.-born women and may lead to disparities in human papillomavirus-related cancers in the future. There is limited research on factors associated with vaccination uptake between these two groups. This study examined the association between place of birth and human papillomavirus vaccine uptake, and what determinants of vaccination attenuate this relationship. METHODS: The 2013-2015 National Health Interview Survey data on women was analyzed in 2016, to determine differences in prevalence of human papillomavirus vaccination between foreign- and U.S.-born women. Multivariate binary logistic regression analysis was used to examine the association between foreign-born status and human papillomavirus vaccine initiation, after controlling for health insurance status, having a usual source of care, obstetrician/gynecologist visits, Pap tests, length of U.S. residency, and citizenship. RESULTS: Human papillomavirus vaccination prevalence varied significantly among women born in different regions of the world. European and South-American women had the highest vaccination rates among all foreign-born women. Compared with U.S.-born women, foreign-born women were significantly less likely to report human papillomavirus vaccine initiation. This relationship was partially attenuated after adjusting for the covariates. Among foreign-born women, Asians were significantly less likely to report human papillomavirus vaccination uptake than white women. Additionally, living in the U.S. for >5 years was significantly associated with vaccine initiation, but attenuated by U.S. citizenship status. CONCLUSIONS: Public health interventions to improve human papillomavirus vaccination need to be developed to address multicultural audiences with limited access to health insurance and health care.
INTRODUCTION: Human papillomavirus vaccination is less prevalent among foreign-born than U.S.-born women and may lead to disparities in human papillomavirus-related cancers in the future. There is limited research on factors associated with vaccination uptake between these two groups. This study examined the association between place of birth and human papillomavirus vaccine uptake, and what determinants of vaccination attenuate this relationship. METHODS: The 2013-2015 National Health Interview Survey data on women was analyzed in 2016, to determine differences in prevalence of human papillomavirus vaccination between foreign- and U.S.-born women. Multivariate binary logistic regression analysis was used to examine the association between foreign-born status and human papillomavirus vaccine initiation, after controlling for health insurance status, having a usual source of care, obstetrician/gynecologist visits, Pap tests, length of U.S. residency, and citizenship. RESULTS: Human papillomavirus vaccination prevalence varied significantly among women born in different regions of the world. European and South-American women had the highest vaccination rates among all foreign-born women. Compared with U.S.-born women, foreign-born women were significantly less likely to report human papillomavirus vaccine initiation. This relationship was partially attenuated after adjusting for the covariates. Among foreign-born women, Asians were significantly less likely to report human papillomavirus vaccination uptake than white women. Additionally, living in the U.S. for >5 years was significantly associated with vaccine initiation, but attenuated by U.S. citizenship status. CONCLUSIONS: Public health interventions to improve human papillomavirus vaccination need to be developed to address multicultural audiences with limited access to health insurance and health care.
Authors: Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg Journal: N Engl J Med Date: 2015-02-19 Impact factor: 91.245
Authors: Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; James A Singleton Journal: MMWR Morb Mortal Wkly Rep Date: 2016-08-26 Impact factor: 17.586
Authors: Peng-Jun Lu; Alfonso Rodriguez-Lainz; Alissa O'Halloran; Stacie Greby; Walter W Williams Journal: Am J Prev Med Date: 2014-10-07 Impact factor: 5.043
Authors: Walter W Williams; Peng-Jun Lu; Alissa O'Halloran; David K Kim; Lisa A Grohskopf; Tamara Pilishvili; Tami H Skoff; Noele P Nelson; Rafael Harpaz; Lauri E Markowitz; Alfonso Rodriguez-Lainz; Carolyn B Bridges Journal: MMWR Surveill Summ Date: 2016-02-05
Authors: Milkie Vu; Carla J Berg; Cam Escoffery; Hyun M Jang; Tien T Nguyen; Lisa Travis; Robert A Bednarczyk Journal: Vaccine Date: 2020-08-20 Impact factor: 3.641
Authors: Eric Adjei Boakye; Wenhui Zeng; Samuel Governor; Shreya Nagendra; Betelihem B Tobo; Matthew C Simpson; Nosayaba Osazuwa-Peters Journal: Prev Med Rep Date: 2019-10-25